not tagged
janssen
['leukemia', '$jnj']
$jnj johnson and johnson says new imbruvica data in fixed-duration combination regimen presented at eha 2022 shows deep, durable response at 3 years in untreated chronic lymphocytic leukemia 
Actionable Global Markets Newswire. Built for Traders, by Traders.

Click the Website Link to Sign up for fast, immediate accesss!